Open Government Portal

This report presents findings on the representation and outcomes of Black people as accused in Canadian criminal courts. This is the first time that national statistics on Black accused in criminal courts are reported in Canada.

Section 4.2 of the Department of Justice Act requires the Minister of Justice to prepare a Charter Statement for every government bill to help inform public and Parliamentary debate on government bills. One of the Minister of Justice’s most important responsibilities is to examine legislation for inconsistency with the Canadian Charter of Rights and Freedoms [“the Charter”]. By tabling a Charter Statement, the Minister is sharing some of the key considerations that informed the review of a bill for inconsistency with the Charter. A Statement identifies Charter rights and freedoms that may potentially be engaged by a bill and provides …

This is the package of briefing materials prepared for the Social Sciences and Humanities Research Council (SSHRC) president's appearance in support of the Minister of Innovation, Science and Industry appearance at the House of Commons Standing Committee on Science and Research on February 2, 2023.

The purpose of this document is to provide an in depth view into the stages to release data and information, in the interest of transparency and Open Government within the RCMP.

Pentachlorophenol is currently registered for industrial uses as a heavy duty wood preservative in Canada. All currently registered pest control products containing pentachlorophenol are considered in this special review (Appendix I of PSRD2020-03).

Before making a special review decision on pymetrozine, Health Canada will consider all comments received from the public in response to PSRD2020-04. A science-based approach will be applied in making a final decision on pymetrozine. Health Canada will then publish a special review decision document, which will include the decision, the reasons for it, a summary of the comments received on the proposed decision, and Health Canada’s response to these comments.

Based on the assessment of the aspects of concern under subsection 17(1) and subsection 17(2) of the Pest Control Products Act, Health Canada’s Pest Management Regulatory Agency, under the authority of the Pest Control Products Act, is confirming the current registration of pymetrozine products for sale and use in Canada with risk mitigation measures (Appendix III). All pest control products containing pymetrozine that are registered in Canada are subject to the special review decision.

Before making a final decision on the special reviews of clothianidin, thiamethoxam and imidacloprid used on cucurbits and their potential risk to squash bees, Health Canada will consider all comments received from the public in response to this consultation document. A science-based approach will be applied in making a final decision on these special reviews. Health Canada will then publish a special review decision document, which will include the decision, the reasons for it, a summary of the comments received on the proposed decision, and Health Canada’s response to these comments.

Evaluation of available scientific information related to the aspect of concern indicated that the potential environmental risks to Eucera pruinosa (squash bee) through exposure to clothianidin, thiamethoxam and imidacloprid used on cucurbits are considered acceptable when used according to the current conditions of use.

Before making a final decision on the special review of iprodione, Health Canada will consider all comments received from the public in response to this consultation document. Health Canada will then publish a special review decision document, which will include the decision, the reasons for it, a summary of the comments received on the proposed decision, and Health Canada's response to these comments.